Management Report
Management Report

4. Corporate Structure

Bayer AG, headquartered in Leverkusen, Germany, is the strategic management holding company for the Bayer Group. Business operations are conducted by the HealthCare, CropScience and MaterialScience subgroups.
Sales by Segment 9M 2010 (9M 2009 in parentheses)
Our subgroups are supported by the Business Services, Technology Services and Currenta service companies, which are reported in the reconciliation as "All Other Segments" along with "Corporate Center and Consolidation."
Key Data by Subgroup and Segment[Table 1]
 
Sales
EBIT
before special items*
EBITDA
before special items*
EBITDA margin
before special items*
 3rd
Quarter
2009
3rd
Quarter
2010
3rd
Quarter
2009
3rd
Quarter
2010
3rd
Quarter
2009
3rd
Quarter
2010
3rd
Quarter
2009
3rd
Quarter
2010
 € million€ million€ million€ million€ million€ million%%
HealthCare3,9364,271786762 1,141 1,099 29.025.7
Pharmaceuticals2,5482,73247546276573130.026.8
Consumer Health1,3881,53931130037636827.123.9
CropScience1,1401,341(16) (4) 108 126 9.59.4
Crop Protection9731,130123311814212.112.6
Environmental Science, BioScience
167

211

(28)

(37)

(10)

(16)

(6.0)

(7.6)
MaterialScience2,0382,665100 260 238 409 11.7 15.3
Reconciliation278304(33) (26) 12 224.37.2 
Group7,3928,581837992 1,499 1,656 20.319.3
         
 First Nine Months 2009First Nine Months 2010First Nine Months 2009First Nine Months 2010First Nine Months 2009First Nine Months 2010First Nine Months 2009First Nine Months 2010
HealthCare11,824 12,445 2,237 2,271 3,314 3,280 28.026.4
Pharmaceuticals7,7698,0111,5211,4702,4042,28130.928.5
Consumer Health4,0554,43471680191099922.422.5
CropScience5,112 5,177 975 701 1,342 1,081 26.320.9
Crop Protection4,2474,1268334981,15281727.119.8
Environmental Science, BioScience
865

1,051

142

203

190

264

22.0

25.1
MaterialScience5,504 7,570 (185) 632 243 1,067 4.414.1
Reconciliation856 884 (72) (78) 60 63 7.07.1 
Group23,296 26,076 2,955 3,526 4,959 5,491 21.321.1
* For definition see "Calculation of EBIT(DA) Before Special Items."

Changes in corporate structure

Effective January 1, 2010, we transferred certain products from the Specialty Medicine to the General Medicine business unit within the Pharmaceuticals segment of the HealthCare subgroup. In addition, organizational changes resulted in the merger of the General Medicine and Women's Healthcare business units and the integration of the Diagnostic Imaging business unit into the Specialty Medicine business unit in the second quarter of 2010. The prior-year figures are restated accordingly.
http://www.stockholders-newsletter-q3-2010.bayer.com/en/corporate-structure.aspx

Copyright © Bayer AG

Print Page

Search

Download Center

Publications

Services

Special Interest